Trials / Sponsors / Nanjing RegeneCore Biotech Co., Ltd.
Nanjing RegeneCore Biotech Co., Ltd.
Industry · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Phase II Trial of RC1416 Injection in Asthma Moderate to Severe Asthma | Phase 2 | 2026-03-10 |
| Recruiting | Phase II Study of RC1416 Injection in COPD Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | 2026-03-06 |
| Recruiting | This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile Hematologic Malignancies | Phase 1 | 2025-03-25 |
| Completed | A Phase Ib Study of RC1416 Injection Moderate to Severe Asthma | Phase 1 | 2024-10-25 |
| Completed | A Phase I Study of RC1416 Injection Healthy Volunteers | Phase 1 | 2023-06-29 |